Track Artelo Biosciences- Warrants (18/06/2024)'s other current liabilities ($1.4M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), ARTLW shows a other current liabilities of $1.4M. That compares with $4.9M in the prior-year period — down 71.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ARTLW's other current liabilities is now $1.4M (was $4.9M) — a 71.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Artelo Biosciences- Warrants (18/06/2024) is outperforming or lagging.
Tracking ARTLW's other current liabilities over time shows whether Artelo Biosciences- Warrants (18/06/2024) is scaling, shrinking, or reshaping that part of the business. The current reading is $1.4M That compares with $4.9M in the prior-year period — down 71.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this other current liabilities page, Stockcircle has Artelo Biosciences- Warrants (18/06/2024)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $1.4M) with ownership activity and broader fundamentals.
Artelo Biosciences- Warrants (18/06/2024)'s other current liabilities is $1.4M; compare it with other Consumer Staples names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.